THE Madras Pharmaceutical
Indian Pharmaceutical Exporter · Immunosuppressants Specialist · $1.4M Total Trade · DGFT Verified
THE Madras Pharmaceutical is an Indian pharmaceutical exporter with a total trade value of $1.4M across 3 products in 3 therapeutic categories. Based on 28 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Tacrolimus ($950.0K), Clindamycin ($300.0K), Telmisartan ($150.0K).
THE Madras Pharmaceutical — Export Portfolio & Destination Treemap
Who is THE Madras Pharmaceutical? — Company Overview & Market Position
Established in 1979, The Madras Pharmaceuticals is a prominent contract research and manufacturing services (CRAMS) organization headquartered in Chennai, India. Founded by five healthcare professionals, the company began with a modest 2,000 sq. ft. facility and a team of five employees. Over the decades, it has expanded significantly, now operating seven state-of-the-art manufacturing sites and employing over 3,000 individuals. The company specializes in producing a diverse range of pharmaceutical formulations, including tablets, capsules, syrups, and injections, catering to various therapeutic categories. With a turnover exceeding INR 500 crore, The Madras Pharmaceuticals has established itself as a leading player in the Indian pharmaceutical industry.
The company's ownership structure is a partnership, with key stakeholders including Mr. A.M. Sulaiman, Dr. Nagappan, Dr. Alagappan, and Mr. Kumaran. Mr. Sulaiman, a first-generation entrepreneur, serves as the Managing Director and has been instrumental in the company's growth and strategic direction. Dr. Nagappan and Dr. Alagappan, both renowned surgeons, play critical roles in the group's strategy and future growth planning. Mr. Kumaran, a committed pharmaceutical professional, heads the domestic business of the group, overseeing operations and business development.